查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2011132

生物促效劑市場：依形態、原料、應用方法和作物類型分類－2026-2032年全球市場預測

Biostimulants Market by Form, Source, Application Method, Crop Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生物促效劑市場價值將達到 50.6 億美元，到 2026 年將成長至 56.6 億美元，到 2032 年將達到 114.7 億美元，年複合成長率為 12.40%。

主要市場統計數據
基準年 2025 50.6億美元
預計年份：2026年 56.6億美元
預測年份 2032 114.7億美元
複合年成長率 (%) 12.40%

隨著監管和商業化需求的不斷成長，將生物促效劑作為提高作物耐受性和營養利用效率的關鍵工具的趨勢日益明顯。

生物促效劑產業正處於轉折點，多種因素共同作用，使其在作物綜合營養策略中的重要性日益凸顯。生物學發現的進步，以及專業種植者和農產品經銷商的廣泛應用，已使生物促效劑從小眾助劑轉變為提高作物抗逆性、養分利用效率和品質的戰略工具。同時，不斷完善的法規結構和對產品功效的強化監測，提高了基於證據的性能標準和供應鏈透明度。因此，製造商、合約開發商和服務供應商正在積極應對，透過更嚴格的產品特性描述、擴展的測試網路以及更清晰的標籤檢視，來闡明其作用機制和適用場景。

由科學創新、策略夥伴關係和監管協調驅動的多方面變革正在提高商業性滲透率和營運嚴謹性。

近年來，在科學日趨成熟、供應鏈不斷發展以及客戶期望轉變的推動下，生物促效劑市場格局發生了巨大變化。微生物發現和製劑科學的創新拓寬了種植者可用的功能性投入品範圍，從而能夠提供客製化的解決方案，以減輕作物脅迫並提高產量和品質。同時，鄰近農業材料領域的產業重組以及老牌農藥生產商與專業生物技術公司之間的策略合作，正在重塑市場進入通路、分銷網路和產品研發資源分配。此外，數位農業和精準施藥系統也為透過區域績效數據和訂閱諮詢服務展現價值創造了新的機會。

為應對關稅帶來的成本壓力，我們正在透過重組採購、配方和在地化策略來審查我們的業務運營，並展現我們的採購韌性。

美國近期實施的關稅措施為生物促效劑價值鏈上的所有相關人員帶來了新的成本和物流挑戰。由於關稅導致某些進口原料和中間投入品的到貨成本增加，迫使製造商重新評估籌資策略、庫存政策和供應商多元化計劃。因此，一些生產商正在加快開發在地採購替代方案，並調整配方以減少對受影響進口產品的依賴。同時，經銷商和配方製造商也在審查定價和合約條款，以在保持獲利能力的同時，滿足對成本敏感的終端用戶的競爭需求。

詳細的分割分析揭示了作物的形態、生物原料、應用途徑和最終用途如何決定技術要求、測試設計和商業化方法。

對產品細分市場的詳細分析揭示了每種物理形態、生物來源、應用方法和最終用途作物的不同發展路徑和商業性動態。顆粒、液體和粉末狀產品各自面臨不同的配方挑戰和應用場景。顆粒適用於土壤施用和機械化播種；液體可快速吸收，適用於葉面噴布和施肥/灌溉平台；粉末在特定供應鏈中具有靈活的劑量控制和儲存優勢。從生物來源的角度來看，胺基酸、腐植酸、微生物製劑、蛋白質水解物和海藻萃取物各自具有獨特的作用機制和市場預期。對於腐植酸而言，需要區分富裡酸組分和腐植酸成分，以明確其溶解度和與土壤化學性質的相互作用。另一方面，微生物製劑需要清晰的分類學和菌株水平的記錄，以明確區分放線菌、細菌、真菌及其目標功能。蛋白質水解物進一步分為兩大類：動物源性和植物來源，這會影響辨識、調控途徑以及對特定作物系統的適用性。

監管要求、通路和生產​​商優先事項的區域差異決定了各個商業化和證據生成策略。

區域趨勢影響著價值的創造地點和商業策略的實施方式，北美、歐洲、中東和非洲以及亞太地區呈現出截然不同的市場動態。在北美，成熟的分銷網路和大型商業生產商的存在正在加速生物促效劑與機械化農業和精準投入系統的結合應用。同時，南北貿易流動影響生物材料在供應鏈中的定位。在歐洲、中東和非洲，複雜的法規環境，加上強力的永續發展議程和零售商主導的品質要求，使得擁有清晰環境記錄和可追溯供應鏈的產品更受青睞。相較之下，在亞太地區，農業的快速現代化和農場規模的差異性使得可擴展、低成本的配方方法和本地技術支援對於更廣泛的應用至關重要。

企業策略和業務活動透過科學差異化、卓越製造和貫穿整個價值鏈的管道整合來定義領導地位。

生物促效劑產業的競爭格局呈現出多元化的態勢，既有技術主導的新興參與企業，也有成熟的農資供應公司和專業服務供應商。技術主導企業通常強調其專有的生物菌株、先進的萃取技術和精準的應用系統，並大力投資測試網路和科學檢驗，以建立信譽。成熟的農業供應公司則利用其廣泛的分銷網路、與種植戶建立的穩固關係以及整合的商業性服務，將生物促效劑融入肥料和作物保護產品組合中進行銷售。專業的生產商和合約開發人員則專注於配方最佳化、大規模生產和法規支持，服務對象包括品牌所有者和自有品牌合作夥伴。

將科學創新轉化為可靠的農業成果、可擴展的生產和穩健的商業性執行所面臨的實際策略挑戰。

產業領導者應採取一系列切實可行的措施，將科學潛力轉化為可重複的農業化學品價值和商業性吸引力。首先，優先投資進行嚴謹且可重複的田間試驗，試驗內容應涵蓋不同的農業生態區域和施用方法，以確保產品功效聲明的可信度和適用性。其次，根據分銷管道的實際情況調整配方開發，設計適用於機械化噴灑、施肥和灌溉系統或零售處理要求的劑型，從而最大限度地減少推廣障礙。第三，實現採購管道多元化，加強與供應商的夥伴關係，並鼓勵在應對力和成本控制能力更強的地區進行生產，以降低關稅和供應中斷的風險。

採用透明的混合方法研究設計，結合對關鍵相關人員的訪談、技術文獻的整合和情境評估，確保了研究的合法性和可操作的見解。

支持這些發現的調查方法採用了多階段方法，兼顧了初步檢驗和嚴謹的二次整合。研究人員透過對生產商、經銷商、配方專家和研發負責人進行結構化訪談，收集了初步信息，以了解田間實踐、推廣障礙和證據要件。這些觀點與技術文獻和同行評審的研究進行了交叉比對，以檢驗作用機制並了解配方在土壤和葉面環境中的相互作用。此外，研究人員還審查了法規結構和註冊指南，以評估其對功效聲明和跨境商業化的影響。

策略整合強調以證據為基礎的商業化、跨職能協作和業務永續營運，並將這些視為長期成功的決定因素。

總之，生物促效劑領域的現狀呈現出科學成熟、監管要求不斷提高以及商業結構不斷演變的特點，這些因素共同提升了機遇，同時也增加了實施難度。相關人員若能投資於嚴格的檢驗、靈活的配方策略和健全的採購體系，將能更有效地獲取生物促效劑在現代作物管理系統中帶來的戰略價值。此外，研發、監管和商業化團隊之間的合作至關重要，只有這樣才能將前景廣闊的生物學發現轉化為種植者信賴並能常規使用的產品。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：生物促效劑市場：依形式分類

  • 顆粒
  • 液體
  • 粉末

第9章：生物促效劑市場：依來源分類

  • 胺基酸
  • 腐植質
    • 富裡酸
    • 腐植酸
  • 微生物來源
    • 放線菌
    • 細菌
    • 真菌
  • 蛋白質水解物
    • 動物源性
    • 植物來源
  • 海藻萃取物

第10章：按應用方法分類的生物促效劑市場

  • 葉面噴布
  • 種子處理
  • 土壤處理
    • 滴灌
    • 溝施

第11章：生物促效劑市場：依作物類型分類

  • 穀類和穀類食品
  • 水果和蔬菜
  • 油籽/豆類
  • 草坪和觀賞植物

第12章：生物促效劑市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：生物促效劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：生物促效劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國生物促效劑市場

第16章：中國生物促效劑市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acadian Seaplants Limited
  • Agricen by Nutrien
  • AgriLife（India）Private Limited
  • Agrinos
  • Agritecno Fertilizantes SL
  • Andermatt Group AG
  • Apple Agro
  • Atlantica Agricola, SA
  • Axeb Biotech SL
  • BASF SE
  • Bayer AG
  • BioAtlantis Ltd.
  • Biobest Group NV
  • BIOIBERICA SAU
  • Biolchim SpA by JM Huber Corporation
Product Code: MRR-43422F546E3C

The Biostimulants Market was valued at USD 5.06 billion in 2025 and is projected to grow to USD 5.66 billion in 2026, with a CAGR of 12.40%, reaching USD 11.47 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.06 billion
Estimated Year [2026] USD 5.66 billion
Forecast Year [2032] USD 11.47 billion
CAGR (%) 12.40%

An integrative orientation that positions biostimulants as critical tools for crop resilience and nutrient efficiency amid heightened regulatory and commercialization demands

The biostimulants sector is at an inflection point, shaped by converging drivers that elevate its importance within integrated crop nutrition strategies. Advances in biological discovery, coupled with growing adoption among professional growers and input distributors, have repositioned biostimulants from niche supplements to strategic tools used to enhance crop resilience, nutrient use efficiency, and quality outcomes. In parallel, evolving regulatory frameworks and increasing scrutiny of product claims have raised the bar for evidence-based performance and supply chain transparency. Consequently, manufacturers, contract developers, and service providers are responding with more rigorous product characterization, expanded trial networks, and clearer labels that articulate modes of action and situational use cases.

Moving from concept to operational deployment, industry participants face the dual challenge of demonstrating consistent agronomic benefits while establishing scalable manufacturing and distribution pathways. This requires a tighter integration of R&D pipelines with commercialization channels so that novel actives and formulations can be validated under real-world conditions. In addition, investment in analytical techniques and biological assays is accelerating, enabling better differentiation among product classes. Given these dynamics, strategic stakeholders should view the current environment as one in which scientific credibility and operational readiness together determine competitive positioning and long-term value creation.

A multifaceted transformation driven by scientific innovation, strategic partnerships, and regulatory harmonization that elevates commercial adoption and operational rigor

The landscape for biostimulants has shifted markedly in recent years, driven by scientific maturation, supply-chain evolution, and shifting customer expectations. Innovations in microbial discovery and formulation science have broadened the palette of functional inputs available to growers, enabling tailored solutions for stress mitigation and yield quality. Meanwhile, consolidation in adjacent agricultural input segments and strategic partnerships between established agrochemical firms and specialist biotech providers are reshaping routes to market, distribution reach, and resource allocation for product development. At the same time, digital agronomy and precision application systems are creating new opportunities to demonstrate value through localized performance data and subscription-based advisory services.

These transformative shifts also encompass the regulatory and commercial environment. Regulators are increasingly focused on standardizing claim substantiation and harmonizing registration pathways, which favors companies that invest in reproducible science and robust field evidence. Additionally, procurement and sourcing strategies are evolving to prioritize traceability, sustainability credentials, and supply continuity, particularly for biologically derived inputs. As a result, organizations that align R&D, regulatory affairs, and commercial functions will be better positioned to capture premium placements and long-term contracts with institutional growers and distributors. In short, the market is moving from early experimentation toward institutional adoption, with competitive advantage accruing to those who can scale validated innovations reliably.

Operational recalibration and sourcing resilience emerging in response to tariff-driven cost pressures that reshape procurement, formulation, and localization strategies

Recent tariff measures introduced by the United States have introduced new cost and logistics considerations for participants across the biostimulants value chain. Tariff-driven increases in the landed cost of certain imported raw materials and intermediate inputs have prompted manufacturers to reassess sourcing strategies, inventory policies, and supplier diversification plans. In consequence, some producers have accelerated development of local supply alternatives or reconfigured formulations to reduce dependency on affected imports. At the same time, distributors and formulators are reevaluating pricing and contract terms to preserve margin while remaining competitive for end users who are sensitive to input costs.

Beyond immediate cost impacts, tariffs have influenced investment decisions and longer-term strategic planning. They have reinforced interest in nearshoring critical manufacturing steps and in vertical integration options that insulate firms from import volatility. Moreover, tariffs have increased the importance of transparent documentation and classification of biological materials to ensure accurate duty treatment and to avoid downstream compliance delays. While tariffs affect multiple nodes across the ecosystem, they also create an impetus for companies to strengthen commercial resilience through multi-sourcing, strategic inventory positioning, and enhanced supplier collaborations. Taken together, these responses reflect a pragmatic recalibration rather than a one-time disruption, with firms embedding tariff risk considerations into procurement and product development roadmaps.

Detailed segmentation analysis revealing how form, biological source, application pathways, and crop end-use determine technical requirements, trial design, and commercialization approaches

A nuanced view of product segmentation reveals distinct development pathways and commercial dynamics for different physical forms, biological sources, application methods, and crop end-uses. Products available as granules, liquids, and powders manifest different formulation challenges and application profiles; granules often align with soil-applied programs and compatibility with mechanized seeding, liquids support foliar and fertigation platforms with rapid uptake, and powders provide flexible dose control and storage advantages for certain supply chains. In terms of biological origin, amino acids, humic substances, microbial inoculants, protein hydrolysates, and seaweed extracts each bring unique modes of action and market expectations. Humic substances demand differentiation between fulvic acid fractions and humic acid constituents to clarify solubility and interaction with soil chemistry, while microbial offerings require clear taxonomy and strain-level documentation that delineates actinomycetes, bacteria, and fungi and their targeted functions. Protein hydrolysates further bifurcate into animal-derived and plant-derived streams, influencing perception, regulatory pathways, and suitability for specific crop systems.

Application method matters as well, with foliar delivery, seed treatments, and soil treatments serving distinct agronomic roles and logistics considerations. Soil-applied products are themselves divided by delivery technique, where drip irrigation integration and furrow application present differing compatibility and adoption profiles across irrigation infrastructures. Finally, crop type segmentation-spanning cereals and grains, fruits and vegetables, oilseeds and pulses, and turf and ornamentals-shapes product claims, trial designs, and channel strategies because grower priorities and crop management rhythms vary significantly. Collectively, these segmentation dimensions suggest that successful commercial approaches will pair precise formulation and evidence with channel-specific commercialization plans that respect the technical constraints and decision drivers of each use case.

Regional differentiation in regulatory requirements, distribution channels, and grower priorities that dictates tailored commercialization and evidence generation strategies

Regional dynamics are influencing where value is created and how commercial strategies are executed, with distinct market mechanics evident across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established distribution networks and a significant presence of large commercial growers accelerate adoption of biostimulants that integrate with mechanized farming and precision input systems, while North-South trade flows affect supply chain positioning for raw biological materials. Europe, Middle East & Africa presents a complex regulatory mosaic alongside strong sustainability agendas and retailer-driven quality requirements that favor products with clear environmental credentials and traceable supply chains. In contrast, Asia-Pacific combines rapid agricultural modernization with heterogeneous farm sizes, producing an environment where scalable, low-cost formulation approaches and local technical support are critical to wider adoption.

These regional distinctions have operational implications. For instance, regulatory compliance pathways and label claims must be adapted to regional authorities and market expectations, which in turn affects evidence generation and labeling strategies. Distribution models also differ; some regions favor direct engagement with large growers and advisory networks, while others rely on robust retail channels and independent distributors. Consequently, companies that tailor commercialization tactics to regional agronomic realities, regulatory frameworks, and channel structures will increase their likelihood of sustained penetration and meaningful growth across diversified geographies.

Corporate strategies and operational behaviors that determine leadership through scientific differentiation, manufacturing excellence, and channel integration across the value chain

Competitive dynamics among companies operating in the biostimulants space reflect a mix of technology-led entrants, incumbent agri-input firms, and specialized service providers. Technology-led firms often emphasize proprietary biological strains, advanced extraction techniques, and targeted application systems, investing heavily in trial networks and scientific validation to build credibility. Incumbent agricultural suppliers leverage broad distribution footprints, established grower relationships, and integrated commercial offerings to bundle biostimulants with fertility and crop protection packages. Specialized manufacturers and contract developers focus on formulation excellence, scale manufacturing, and regulatory support, catering to both branded owners and private-label partners.

Across these archetypes, strategic behaviors converge around several themes: vertical partnerships that secure raw biological inputs and R&D collaborations that accelerate product differentiation, M&A activity that fills capability gaps or expands geographic reach, and enhanced focus on regulatory and claims substantiation to meet evolving standards. Operational excellence in manufacturing and quality control also distinguishes market leaders, as does investment in digital agronomy services that demonstrate practical benefits at the field level. Ultimately, companies that successfully combine scientific rigor, manufacturing reliability, and commercial channel strength will be best positioned to convert technical promise into consistent customer outcomes and durable commercial relationships.

Practical strategic imperatives for converting scientific innovation into reliable agronomic outcomes, scalable manufacturing, and resilient commercial execution

Industry leaders should adopt a pragmatic set of actions that translate scientific potential into reproducible agronomic value and commercial traction. First, prioritize investment in rigorous, replicated field trials that reflect diverse agroecological zones and application methods so that claims are robust and transferable. Second, align formulation development with channel realities by designing form types that suit mechanized application, fertigation systems, or retail handling requirements to minimize adoption friction. Third, diversify sourcing and enhance supplier partnerships to reduce exposure to tariff or supply disruptions while pursuing localized manufacturing where it improves responsiveness and cost control.

In parallel, strengthen regulatory and quality functions to ensure claims substantiation and label clarity across jurisdictions, and integrate digital data capture to document performance at scale for growers and distributors. Additionally, cultivate go-to-market collaborations with distributors, advisors, and ag-technology partners to embed products into integrated crop management programs. Finally, consider strategic portfolio balancing between innovative, higher-margin offerings and pragmatic, widely adoptable formulations that build recurring revenue streams. Taken together, these actions create a resilient platform for sustainable growth and reduce execution risk in a rapidly professionalizing sector.

A transparent mixed-methods research design combining primary stakeholder interviews, technical literature synthesis, and scenario evaluation to ensure defensible and actionable insights

The research approach underpinning these insights combined a multi-step methodology that balances primary validation with rigorous secondary synthesis. Primary inputs included structured interviews with growers, distributors, formulation specialists, and R&D leaders to capture on-the-ground practices, adoption barriers, and evidence requirements. These perspectives were triangulated with technical literature and peer-reviewed studies to validate modes of action and to understand formulation interactions across soil and foliar environments. In addition, regulatory frameworks and registration guidelines were reviewed to assess implications for claim substantiation and cross-border commercialization.

Analytical steps included cross-segmentation mapping to identify where form, source, application, and crop intersections create differentiated technical and commercial needs. Scenario evaluation techniques were applied to explore supply-chain and tariff sensitivities, and expert panels provided iterative validation of preliminary findings. Throughout the process, emphasis was placed on reproducible methods and transparent documentation of assumptions so that stakeholders can trace line-of-sight from evidence to recommendation. This mixed-methods approach yields a defensible interpretation of current dynamics and practical guidance for operational decision-making.

A strategic synthesis that emphasizes evidence-based commercialization, cross-functional alignment, and operational resilience as the determinants of long-term success

In conclusion, the current phase of the biostimulants sector is characterized by maturation of science, increasing regulatory expectations, and evolving commercial architectures that together raise both opportunity and execution requirements. Stakeholders that invest in rigorous validation, adaptable formulation strategies, and resilient sourcing will be better equipped to capture the strategic value that biostimulants can deliver in modern crop management systems. Moreover, alignment between R&D, regulatory, and commercial teams is essential to convert promising biological discoveries into products that growers can trust and adopt routinely.

Looking ahead, the sector's progress will hinge on continued improvements in evidence generation, clearer regulatory pathways, and stronger commercialization partnerships that integrate biostimulants into broader agronomic solutions. By focusing on reproducible benefits, operational scalability, and market-tailored approaches, organizations can navigate the complexity of the current landscape and position themselves for long-term relevance and impact within sustainable agriculture.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biostimulants Market, by Form

  • 8.1. Granule
  • 8.2. Liquid
  • 8.3. Powder

9. Biostimulants Market, by Source

  • 9.1. Amino Acids
  • 9.2. Humic Substances
    • 9.2.1. Fulvic Acid
    • 9.2.2. Humic Acid
  • 9.3. Microbial
    • 9.3.1. Actinomycetes
    • 9.3.2. Bacteria
    • 9.3.3. Fungi
  • 9.4. Protein Hydrolysates
    • 9.4.1. Animal Derived
    • 9.4.2. Plant Derived
  • 9.5. Seaweed Extract

10. Biostimulants Market, by Application Method

  • 10.1. Foliar
  • 10.2. Seed Treatment
  • 10.3. Soil Treatment
    • 10.3.1. Drip Irrigation
    • 10.3.2. Furrow Application

11. Biostimulants Market, by Crop Type

  • 11.1. Cereals & Grains
  • 11.2. Fruits & Vegetables
  • 11.3. Oilseeds & Pulses
  • 11.4. Turf & Ornamentals

12. Biostimulants Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biostimulants Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biostimulants Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Biostimulants Market

16. China Biostimulants Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Acadian Seaplants Limited
  • 17.6. Agricen by Nutrien
  • 17.7. AgriLife (India) Private Limited
  • 17.8. Agrinos
  • 17.9. Agritecno Fertilizantes SL
  • 17.10. Andermatt Group AG
  • 17.11. Apple Agro
  • 17.12. Atlantica Agricola, S.A.
  • 17.13. Axeb Biotech SL
  • 17.14. BASF SE
  • 17.15. Bayer AG
  • 17.16. BioAtlantis Ltd.
  • 17.17. Biobest Group NV
  • 17.18. BIOIBERICA S.A.U.
  • 17.19. Biolchim S.p.A. by J.M. Huber Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOSTIMULANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOSTIMULANTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOSTIMULANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOSTIMULANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOSTIMULANTS MARKET SIZE, BY GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOSTIMULANTS MARKET SIZE, BY GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOSTIMULANTS MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOSTIMULANTS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOSTIMULANTS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOSTIMULANTS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FULVIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FULVIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FULVIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ACTINOMYCETES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ACTINOMYCETES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ACTINOMYCETES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOSTIMULANTS MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOSTIMULANTS MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOSTIMULANTS MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ANIMAL DERIVED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ANIMAL DERIVED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ANIMAL DERIVED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PLANT DERIVED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PLANT DERIVED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PLANT DERIVED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEAWEED EXTRACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEAWEED EXTRACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEAWEED EXTRACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOSTIMULANTS MARKET SIZE, BY DRIP IRRIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOSTIMULANTS MARKET SIZE, BY DRIP IRRIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOSTIMULANTS MARKET SIZE, BY DRIP IRRIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FURROW APPLICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FURROW APPLICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FURROW APPLICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOSTIMULANTS MARKET SIZE, BY CEREALS & GRAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOSTIMULANTS MARKET SIZE, BY CEREALS & GRAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOSTIMULANTS MARKET SIZE, BY CEREALS & GRAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOSTIMULANTS MARKET SIZE, BY OILSEEDS & PULSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOSTIMULANTS MARKET SIZE, BY OILSEEDS & PULSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOSTIMULANTS MARKET SIZE, BY OILSEEDS & PULSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOSTIMULANTS MARKET SIZE, BY TURF & ORNAMENTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOSTIMULANTS MARKET SIZE, BY TURF & ORNAMENTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOSTIMULANTS MARKET SIZE, BY TURF & ORNAMENTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOSTIMULANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BIOSTIMULANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOSTIMULANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 167. GCC BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 169. GCC BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 170. GCC BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 171. GCC BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 194. G7 BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 196. G7 BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 197. G7 BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 198. G7 BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 199. G7 BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 200. G7 BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 203. NATO BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 205. NATO BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 206. NATO BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 207. NATO BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 208. NATO BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 209. NATO BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)